ArticleJournal of Alzheimer's disease reports

Lecanemab real-world treatment outcomes from cohort study in early Alzheimer's disease.

Alyanna Ferrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.